Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 9:13 pm Purchase | 2025-03-31 | 13G | Ernexa Therapeutics Inc. ERNA | John D. Halpern | 398,122 9.600% | 55,683 (+16.26%) | Filing History |
| 2025-02-14 8:36 pm Purchase | 2024-10-29 | 13G | Ernexa Therapeutics Inc. ERNA | John D. Halpern | 342,439 9.990% | 342,439 (New Position) | Filing History |
| 2024-01-31 07:05 am Purchase | 2023-12-31 | 13G | Ernexa Therapeutics Inc. ERNA | John D. Halpern | 36,726 9.990% | 6,574 (+21.80%) | Filing History |
| 2023-01-31 4:05 pm Purchase | 2023-01-31 | 13G | Ernexa Therapeutics Inc. ERNA | John D. Halpern | 30,152 8.800% | 74 (+0.25%) | Filing History |
| 2022-12-05 5:20 pm Sale | 2022-12-02 | 13G | Ernexa Therapeutics Inc. ERNA | John D. Halpern | 30,078 8.800% | -286,405 (-90.50%) | Filing History |
| 2021-05-24 1:03 pm Purchase | 2021-03-25 | 13G | Ernexa Therapeutics Inc. ERNA | John D. Halpern | 15,824 11.400% | 15,824 (New Position) | Filing History |